Ovarian cancer, oral contraceptives, and BRCA mutations [1] [multiple letters]

New England Journal of Medicine

Volumn 345, Issue 23, 2001, Pages 1706-1707

  Narod, Steven A ^a   Sun, Ping ^a   Risch, Harvey A ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; ORAL CONTRACEPTIVE AGENT;

CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG USE; FEMALE; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; JEW; LETTER; MAJOR CLINICAL STUDY; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; RISK ASSESSMENT;

CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL; FEMALE; GENES, BRCA1; GENES, BRCA2; HUMANS; JEWS; MUTATION; ODDS RATIO; OVARIAN NEOPLASMS; PATIENT SELECTION;

EID: 0035818882     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200112063452312     Document Type: Letter

References (0)